Business Description
Astec Lifesciences Ltd
ISIN : INE563J01010
Compare
Compare
Traded in other countries / regions
ASTEC.India IPO Date
2009-11-25Description
Astec Lifesciences Ltd is engaged in producing agrochemicals and pharmaceutical intermediates. The company's products include agrochemicals, such as Tebuconazole, Propiconazole, Hexaconazole, Difenoconazole, Epoxiconazole, Cyproconazole, Flutriafol, Tricyclazole, Metalaxyl and lambda-cyhalothrin, and intermediates. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.43 | |||||
| Debt-to-Equity | 1.09 | |||||
| Debt-to-EBITDA | -56.72 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.99 | |||||
| Beneish M-Score | -2.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.3 | |||||
| 3-Year EBITDA Growth Rate | -3 | |||||
| 3-Year EPS without NRI Growth Rate | -21 | |||||
| 3-Year Book Growth Rate | 19.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.7 | |||||
| 9-Day RSI | 44.76 | |||||
| 14-Day RSI | 46.8 | |||||
| 6-1 Month Momentum % | -0.37 | |||||
| 12-1 Month Momentum % | -16.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.93 | |||||
| Quick Ratio | 0.36 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 284.77 | |||||
| Days Sales Outstanding | 135.45 | |||||
| Days Payable | 163.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.13 | |||||
| Forward Dividend Yield % | 0.13 | |||||
| 5-Year Yield-on-Cost % | 0.13 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -3.59 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.44 | |||||
| Operating Margin % | -10.97 | |||||
| Net Margin % | -11.81 | |||||
| FCF Margin % | -9.88 | |||||
| ROE % | -12.34 | |||||
| ROA % | -5.37 | |||||
| ROIC % | -4.48 | |||||
| ROC (Joel Greenblatt) % | -5.92 | |||||
| ROCE % | -8.74 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 64.22 | |||||
| PS Ratio | 5.36 | |||||
| PB Ratio | 5.86 | |||||
| Price-to-Tangible-Book | 6.12 | |||||
| Price-to-Operating-Cash-Flow | 31.01 | |||||
| EV-to-EBIT | -64.35 | |||||
| EV-to-EBITDA | -360.54 | |||||
| EV-to-Revenue | 6.36 | |||||
| EV-to-FCF | -64.36 | |||||
| Price-to-Projected-FCF | 46.75 | |||||
| Price-to-Median-PS-Value | 1.56 | |||||
| Earnings Yield (Greenblatt) % | -1.55 | |||||
| FCF Yield % | -1.84 | |||||
| Forward Rate of Return (Yacktman) % | 6.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Astec Lifesciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 4,314.044 | ||
| EPS (TTM) (₹) | -25.98 | ||
| Beta | 0.49 | ||
| Volatility % | 40.53 | ||
| 14-Day RSI | 46.8 | ||
| 14-Day ATR (₹) | 56.735649 | ||
| 20-Day SMA (₹) | 1220.8975 | ||
| 12-1 Month Momentum % | -16.27 | ||
| 52-Week Range (₹) | 825.05 - 1538.7 | ||
| Shares Outstanding (Mil) | 19.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Astec Lifesciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Astec Lifesciences Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Astec Lifesciences Ltd Frequently Asked Questions
What is Astec Lifesciences Ltd(NSE:ASTEC)'s stock price today?
The current price of NSE:ASTEC is ₹1180.55. The 52 week high of NSE:ASTEC is ₹1538.70 and 52 week low is ₹825.05.
When is next earnings date of Astec Lifesciences Ltd(NSE:ASTEC)?
The next earnings date of Astec Lifesciences Ltd(NSE:ASTEC) is .
Does Astec Lifesciences Ltd(NSE:ASTEC) pay dividends? If so, how much?
The Dividend Yield %  of Astec Lifesciences Ltd(NSE:ASTEC) is 0.13% (As of Today), Highest Dividend Payout Ratio of Astec Lifesciences Ltd(NSE:ASTEC) was 0.49. The lowest was 0.03. And the median was 0.09. The  Forward Dividend Yield % of Astec Lifesciences Ltd(NSE:ASTEC) is 0.13%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers